Singapore approves DKSH's HPV cervical lesion spray gel
DKSH Healthcare secured Singapore regulatory clearance for Colpofix, a prescription vaginal spray gel device targeting HPV-related cervical lesions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.